基于银或壳聚糖的抗菌治疗性服装与非抗菌治疗性服装在中重度特应性皮炎患者中的有效性比较(ABC试验):一项实用性随机对照试验的研究方案
ABC试验为实用性随机对照双盲多中心研究,计划纳入165例0至80岁中重度特应性皮炎患者,1:1:1随机分为非抗菌治疗性服装组、基于壳聚糖的抗菌治疗性服装组和基于银的抗菌治疗性服装组,干预12个月,主要结局为12个月时湿疹面积和严重度指数较基线的变化。
要点
- 研究比较抗菌与非抗菌治疗性服装在中重度特应性皮炎中的有效性。
- 计划纳入165例0至80岁患者,随机分为三组,干预12个月。
- 主要结局为12个月时湿疹面积和严重度指数较基线的变化。
核心结论
- 该试验将提供抗菌治疗性服装对特应性皮炎患者有效性、成本效果和安全性的数据。
研究设计与样本
- 实用性随机对照双盲多中心试验,比较基于银或壳聚糖的抗菌治疗性服装与非抗菌治疗性服装在中重度特应性皮炎患者中的有效性。
- 计划纳入165例0至80岁诊断为中重度特应性皮炎的患者,在Erasmus MC大学医学中心、格罗宁根大学医学中心、乌得勒支大学医学中心、阿姆斯特丹大学医学中心和圣安东尼斯医院(Nieuwegein)开展。
- 患者按1:1:1随机分为三组:A组接受不含抗菌剂的治疗性服装,B组接受基于壳聚糖的减少微生物生长的治疗性服装,C组接受基于银的抗菌服装。
- 所有治疗性服装在12个月干预期内夜间穿着,常规治疗继续。
- 主要目标为评估抗菌服装(银组和壳聚糖组)与非抗菌服装相比,12个月时湿疹面积和严重度指数较基线的变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects 10 to 20% of children and between 2 and 15% of the adults in Western Europe. Since 2000, therapeutic clothing or functional textiles based on silver or chitosan as antibacterial agents were introduced for AD. These agents aim to reduce skin colonization with Staphylococcus (S.) aureus. Increased colonization with S. aureus is correlated with increased AD severity. The antimicrobial effects of silver and chitosan have been demonstrated before. At this point, there is insufficient evidence for the effectiveness of antibacterial therapeutic clothing in patients with AD. METHODS: This is a pragmatic randomized controlled double-blind multi-center trial comparing the effectiveness of antibacterial therapeutic clothing based on silver or chitosan as compared with non-antibacterial therapeutic clothing in patients with moderate to severe AD. A total of 165 participants, aged 0 to 80, diagnosed with moderate to severe AD are included. The study is performed in the Erasmus MC University Medical Center, University Medical Center Groningen, University Medical Center Utrecht, Amsterdam University Medical Centers, and St. Antonius Hospital Nieuwegein. Patients will be randomized 1:1:1 into one of the three intervention groups: group A will receive therapeutic clothing without antimicrobial agents, group B will receive microbial growth reducing therapeutic clothing based on chitosan, and group C will receive antimicrobial clothing based on silver. All therapeutic clothing is to be worn at night during the 12-month intervention period. Usual care is continued. The primary objective is to assess the effectiveness of antibacterial clothing (silver and chitosan group) as compared to non-antibacterial clothing assessed with the Eczema Area and Severity Index at 12 months compared to baseline. Secondary outcomes include between-group differences in physician- and patient-reported outcome measures, topical therapy use, S. aureus skin colonization, and safety. Data will be collected at baseline and after 1 month, 3 months, 6 months, and 12 months. A cost-effectiveness analysis will be performed. DISCUSSION: This trial will provide data on the effectiveness, cost-effectiveness, and safety of antibacterial therapeutic clothing for patients with AD. TRIAL REGISTRATION: ClinicalTrials.gov NCT04297215. Registered on 5 March 2020.
引用
- Ragamin A, Fieten KB, Tupker RA, et al. The effectiveness of antibacterial therapeutic clothing based on silver or chitosan as compared with non-antibacterial therapeutic clothing in patients with moderate to severe atopic dermatitis (ABC trial): study protocol for a pragmatic randomized controlled trial. Trials. 2021. PMID: 34895292. doi:10.1186/s13063-021-05836-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。